Nearly all our medical research is wrong

What do we know about the state of life sciences and medical research? It’s a $200B market, takes an entire decade to bring a new medicine to market, and has a serious issue of lack of reproducibility (like when a biotech giant found only 11% of 53 landmark cancer studies could be confirmed.) 

That's why we're thrilled to back Misfit and AgaMatrix co-founder Sridhar Iyengar's latest endeavor, Elemental Machines, which announced their $2.5M round and suite of connected lab products to better track scientific experiments—already cutting research time by 6+ months for some customers.


Company Amt Investors Source
Pear Therapeutics $20M 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Bridge Builders Collaborative MedCity News
Elemental Machines $2.5M Founders Fund, Max Levchin, Project 11 Ventures, 2M Companies, Rock Health TechCrunch

Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.